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sitivity, specificity, positive and negative predictive values of 
various NIHSS thresholds to capture the absence of signifi-
cant disability (mRS  ! 3) were calculated. General linear mod-
els, controlling for age, educational level and different clini-
cal manifestations frequently observed in CADASIL, were 
used to evaluate the relationships between NIHSS and clini-
cal severity.  Results: In the whole cohort, 45 (20.5%) subjects 
presented with mRS  6 3, but only 16 (7.3%) had NIHSS  1 5. All 
but 1 subject with NIHSS  1 5 showed mRS  6 3. NIHSS  ^  5 had 
an 85.3% positive predictive value for no or slight disability 
with only 33.3% specificity. The NIHSS, MMSE score and pres-
ence or absence of gait disturbances were found to be 
strongly and independently correlated with disability (all
p  ! 0.001). Altogether, they accounted for 73% of the vari-
ance of mRS in contrast with the NIHSS alone accounting for 
only 50% of this variance. Among patients with NIHSS  ^  5, 
subjects with mRS  6 3 showed a lower MMSE score than 
those with mRS  ! 3 (p  ! 0.001). All patients with NIHSS  ^  5 
but with mRS  6 3 presented either with gait disturbances or 
MMSE score  ! 25.  Conclusions: The present results suggest 
that the NIHSS cannot reflect the extent of neurological def-
icit and clinical severity in subjects with lacunar infarctions 
in the context of a chronic and diffuse small vessel disease. 
A specific and global neurological scale, including the as-
sessment of cognitive and gait performances, should be de-
veloped for ischemic cerebral microangiopathy.
 Copyright © 2012 S. Karger AG, Basel
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 Abstract
 Background: The National Institutes of Health Stroke Scale 
(NIHSS) is widely used to measure neurological deficits, eval-
uate the effectiveness of treatment and predict outcome in 
acute ischemic stroke. It has also been used to measure the 
residual neurological deficit at the chronic stage after ische-
mic events. However, the value of NIHSS in ischemic cerebral 
small vessel disease has not been specifically evaluated. The 
purpose of this study was to investigate the link between the 
NIHSS score and clinical severity in a large population of sub-
jects with CADASIL (cerebral autosomal dominant arteriopa-
thy with subcortical infarcts and leukoencephalopathy), a 
unique model to investigate the pathophysiology and natu-
ral history of ischemic small vessel disease.  Methods: Demo-
graphic and clinical data of 220 patients with one or more 
lacunar infarcts confirmed by MRI examination and enrolled 
from a prospective cohort study were analyzed. Detailed 
neurological examinations, including evaluation of the 
 NIHSS and modified Rankin Scale score (mRS) for evaluating 
the clinical severity, were performed in all subjects. The sen-
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 Introduction
 The National Institutes of Health Stroke Scale (NIHSS) 
is widely used to assess the clinical severity in acute isch-
emic stroke  [1] . It is considered as an equilibrated tool for 
evaluating multiple aspects of the neurological status af-
ter stroke including motor, sensory, visuospatial or lan-
guage deficits as well as ataxia, hemianopia or decreased 
consciousness  [1] . The NIHSS is also a practical and wide-
ly validated scale that can be used in daily practice to pre-
dict stroke outcome and for assessing the effectiveness of 
acute stroke treatment  [2–8] . At 3 months, in addition to 
the modified Rankin Scale (mRS) mostly chosen for eval-
uating disability and dependence  [9] , the NIHSS has been 
used to capture the residual neurological deficit at a dis-
tance from the ischemic event  [10, 11] . At the early or late 
stage of stroke events, it is strongly related to dependence 
 [5, 12] . 
 The value of the NIHSS in patients with chronic lacu-
nar infarcts, particularly in the setting of diffuse cerebral 
small vessel disease (CSVD) has not been evaluated spe-
cifically. Herein, we sought to determine the extent to 
which the neurological evaluation as measured by the
NIHSS can capture the severity of clinical deficits leading 
to disability and dependence in CADASIL (cerebral auto-
somal dominant arteriopathy with subcortical infarcts 
and leukoencephalopathy), a unique model of pure and 
diffuse ischemic CSVD. 
 Methods
 Two hundred and twenty subjects having at least 1 identified 
lacunar infarction were drawn from a large prospective cohort of 
genetically confirmed CADASIL patients. The complete study de-
sign has been detailed elsewhere  [13] . Briefly, in all cases, clinical, 
demographic and MRI data were collected. Detailed neurological 
examinations, including evaluation of the NIHSS and mRS, were 
performed in all subjects at baseline. Clinical severity was mea-
sured by mRS and categorized as favorable when the patient re-
mained independent (score 0–2) or poor when he became depen-
dent (score 3–5). The sensitivity, specificity, positive and negative 
predictive values for various NIHSS cut points to detect the inde-
pendence measured by mRS were calculated. In the whole sample, 
association between NIHSS and mRS was examined using gen-
eral linear model controlling for age. To further explore the po-
tential factors influencing dependence, clinical manifestations 
frequently observed in CADASIL (psychiatric symptoms, i.e. 
mainly mood disturbances, gait disturbances, disequilibrium, 
urinary disturbances and cognitive function measured as MMSE 
score) and educational level were also added to the model. Since 
all patients but 1 with NIHSS  1 5 presented with mRS  1 3, further 
stratified comparisons between subjects with lower mRS ( ! 3) and 
higher mRS ( 6 3) were performed in subjects with NIHSS  ^  5. 
Comparison of the mean MMSE score between these two sub-
groups was performed by using the independent-sample t test. 
Statistical analyses were performed using SPSS version 20.0 for 
Windows (SPSS Inc.) All p values were two-tailed, and the crite-
rion for significance was p  ! 0.05.
 Results
 The main characteristics of the individuals included 
in the study are summarized in  table 1 . The mean NIHSS 
and mRS values were 1.71 and 1.28, respectively, in the 
whole population. Forty-five (20.5%) CADASIL patients 
had mRS scores  6 3, only 16 (7.3%) presented with NIHSS 
scores  1 5. Subjects with NIHSS  ^  1 were unlikely to pres-
ent with mRS  6 3, while all but 1 of those with NIHSS  1 5 
presented with mRS  6 3 ( table 2 ).
 Table 3 shows the sensitivity, specificity, positive and 
negative predictive values for various NIHSS thresholds 
to detect undisabled or minor disabled subjects measured 
by mRS. A higher threshold led to a higher sensitivity, 
though a lower cutoff point resulted in a higher specific-
ity. The positive predictive value of NIHSS  ^  5 for captur-
ing independence was 85.3%, its negative predictive value 
was 93.8%. The sensitivity of NIHSS  ^  5 for this purpose 
was found excellent (99.4%), while its specificity was only 
33.3%. Even with NIHSS  ^  2, the specificity was lower 
than 80%. 
 Table 1.  Main characteristics of patients with CADASIL (n = 220)
 Demographic data 
 Age, years
Range 
 53.35810.18 
 28–77 
 Male gender  110/220 (50) 
 History of stroke   166/220 (75.5) 
 Psychiatric symptoms    112/220 (50.9) 
 Gait disturbance  86/220 (39.1) 
 Disequilibrium   78/220 (35.5) 
 Dementia   34/220 (15.5) 
 Neurological scores 
 NIHSS
Range 
 1.7183.28
 0–25 
 mRS
Range 
 1.2881.51
 0–5 
 MMSE
Range 
 25.9485.03
 6–30 
 V alues are means 8 SD or numbers with percentages in pa-
rentheses. 
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 In the overall population, the NIHSS increased with 
the severity of mRS after adjustment for age (p  ! 0.001) 
and explained 50% of the variance in mRS. However, 14.7 
and 6.4% of patients with NIHSS  ^  5 were found to have 
an mRS  6 3 and  6 4, respectively ( fig. 1 ). 
 To further explore the impact of different clinical 
symptoms frequently observed in CADASIL on disabili-
ty, a general linear model controlling for age, educational 
level and for different clinical parameters, including the 
NIHSS, was produced. Both the NIHSS, the MMSE score 
and the presence or absence of gait disturbances were 
found strongly and independently associated with the se-
verity of disability as assessed by the mRS (all p  ! 0.001). 
All together, these three clinical parameters accounted 
for 73% of the variance of mRS. 
 Among patients with NIHSS  ^  5, subjects with mRS 
 6 3 had a much lower MMSE score than those with mRS 
 ! 3 (20.38  8 7.43 vs. 27.35  8 2.73, p  ! 0.001). After fur-
ther adjusting for age and educational level, this differ-
ence still remained significant (p  ! 0.001). Among sub-
jects scoring  ^  5 on the NIHSS but whose mRS was  1 3, 
63.3% presented with psychiatric symptoms, 90.0% with 
gait disturbances, 73.3% with balance troubles, 60.0% 
with urinary disturbances, and 56.7% scored less than 25 
on the MMSE ( fig. 2 ); finally, 100% of these individuals 
presented either with gait disturbances or an MMSE 
score  ! 25. 
 Discussion
 To our knowledge, this is the first study of NIHSS in 
patients with chronic lacunar infarctions detected using 
MRI examination in the setting of CSVD. The results ob-
tained in CADASIL showed that the neurological evalu-
ation by NIHSS is not specifically related to the severity 
of disability. Values of NIHSS  ^  5 would result in a false 
prediction of independence in more than two thirds of 
 Table 2.  Distribution of clinical severity (defined by mRS) by
NIHSS score
 NIHSS
 score 
 n  m RS score 
 <3  ≥3 
0  111  110 (99.1) 1 (0.9) 
1 40 35 (87.5) 5 (12.5) 
2 19 15 (78.9) 4 (21.1) 
3 18 8 (44.4)  10 (55.6) 
4 11 4 (36.4) 7 (63.6) 
5 5 2 (40.0) 3 (60.0) 
7 7 0 7 (100) 
8 2 0 2 (100) 
9 2 0 2 (100) 
 12 1 0 1 (100) 
 17 1 0 1 (100) 
 19 2 1 (50.0) 1 (50.0) 
 25 1 0 1 (100) 
 Results are numbers with percentages in parentheses. 
 
 
 Table 3.  Sensitivity, specificity, positive predictive and negative 
predictive values (%) of NIHSS assessment of clinical severity as 
measured by mRS
NIHSS Sensitivity Specificity Positive
predictive value
Negative
predictive value
 ≤ 1  82.9  86.7  96.0  56.5 
 ≤ 2  91.4  77.8  94.1  70.0 
 ≤ 3  96.0  55.6  89.4  78.1 
 ≤ 4  98.3  40.0  86.4  85.7 
 ≤ 5  99.4  33.3  85.3  93.8 
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 Fig. 1. Distribution of mRS score among 
subjects with NIHSS  ^  5. 
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cases. Even using NIHSS  ^  2 would result in a similar 
false prediction in a quarter of cases.
 The present results are in contrast with data obtained 
from acute stroke patients whose NIHSS  1 5 at 3 months 
was found to have a sensitivity of 72% and a specificity of 
92% for capturing dependency  [12] . This discrepancy 
may have several origins. First, the NIHSS was measured 
at a distance from stroke events in CADASIL patients 
while it was recorded early after occurrence of the deficit 
in most previous samples  [3–8] . Second, only few subjects 
with lacunar infarcts were included in these studies in 
contrast to our population all individuals of which were 
confirmed to have such cerebral lesions by MRI investi-
gations  [3–6, 12] . Finally, the results may also stem from 
the nature of the NIHSS itself which does not directly as-
sess neurological functions with respect to disability or 
handicap as much as focal neurological deficits observed 
at the basic clinical examination. Moreover, the NIHSS is 
strongly weighted by deficits of cortical origin while ma-
jor components of disability in CSVD such as cognitive 
decline or gait disturbances are not currently assessed. In 
the present study, more than half of CADASIL patients 
with NIHSS  ! 5 but mRS  1 3 had actually altered cogni-
tive performances in line with previous data showing that 
stroke patients with predominantly cognitive dysfunc-
tion can present with low NIHSS values despite a large 
disabling stroke  [14] . All of these CADASIL patients pre-
sented with either gait disturbances or cognitive decline. 
In line, we observed in CADASIL that the variance of 
mRS was better explained with combining the NIHSS to 
other clinical parameters such as the presence of gait dis-
turbances and MMSE score than with its use in isolation. 
 Altogether, the results of this study suggest that the 
evaluation of focal neurological deficits as performed us-
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ing the NIHSS cannot substitute for a comprehensive neu-
rological examination including the assessment of cogni-
tive and gait performances in the evaluation of clinical 
severity in CSVD. The present data illustrate that a spe-
cific and global neurological scale for evaluating the clin-
ical severity of patients with lacunar infarctions particu-
larly in the setting of CSVD might be developed in future.
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